A NOVEL β -GLOBIN VARIANT: Hb POÇOS DE CALDAS [ β ...
Transcript of A NOVEL β -GLOBIN VARIANT: Hb POÇOS DE CALDAS [ β ...
SHORT COMMUNICATION
A NOVEL b-GLOBIN VARIANT: Hb POCOS DECALDAS [b61(E5)Lys!Gln]
Elza M. Kimura,1 Simone B. Jorge,1 Satie H. Ogo,3
Maristela Cesquini,3 Dulcineia M. Albuquerque,2
Andre Fattori,2 Sara T. O. Saad,2 Fernando F. Costa,2
and Maria F. Sonati1,*
1Department of Clinical Pathology and 2Department of Clinical
Medicine, School of Medical Sciences and 3Department of
Biochemistry, Institute of Biological Sciences,
State University of Campinas, UNICAMP, P.O. Box 6111,
Campinas (SP), Brazil 13083-970
A novel hemoglobin (Hb) variant was found during a screening program for
hemoglobinopathies in blood donors at the Hematology Center of the State
University of Campinas, Campinas, Brazil. The carrier was a 30-year-old
Caucasian woman of Native Indian and Italian origin, born in Pocos de Caldas,
a city in the State of Minas Gerais, Southeastern Brazil. The new Hb was
distinguished as an abnormal band, faster than Hb A, at alkaline pH (Fig. 1a), that
moved like Hb A at acid pH.[1] Isoelectrofocusing (IEF) with an REP Hemoglobin
IEF Kit (Helena Laboratories, Beaumont, TX, USA), at pH ranges varying from
6.0 to 8.0, showed a fast band moving to the anode (Fig. 1b). Urea Triton X-100
polyacrylamide gel electrophoresis[2] showed the presence of a b chain variant that
was barely discernible from the normal b chain (Fig. 1c). Stability tests[1] were
normal. The Hb oxygen equilibria were performed by the method of Rossi-Fanelli
and Antonini,[3] in stripped Hb and in the presence of organic polyphosphate at a
pH between 7.0 and 8.0. Corroborating the clinical manifestation, Hb Pocos de
Caldas showed functional properties similar to that of normal Hb.
Molecular analyses involved the amplification of a 661 bp fragment of the
b-globin gene, using primers P1 (50-GCCAAGGACAGGTACGGCTGTCATC-30)
*Corresponding author. Fax: þ(55-19) 3788-9434; E-mail: [email protected]
385
DOI: 10.1081=HEM-120016375 0363-0269 (Print); 1532-432X (Online)
Copyright # 2002 by Marcel Dekker, Inc. www.dekker.com
HEMOGLOBIN
Vol. 26, No. 4, pp. 385–388, 2002
©2002 Marcel Dekker, Inc. All rights reserved. This material may not be used or reproduced in any form without the express written permission of Marcel Dekker, Inc.
MARCEL DEKKER, INC. • 270 MADISON AVENUE • NEW YORK, NY 10016
Hem
oglo
bin
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f C
onne
ctic
ut o
n 10
/30/
14Fo
r pe
rson
al u
se o
nly.
Figure 1. a) Hb electrophoresis on cellulose acetate at pH 8.9. Lane 1: normal control; lane 2:
proband; lane 3: proband’s mother; lane 4: proband’s brother; lane 5: proband’s sister. b) IEF showing
Hb Pocos de Caldas in relation to Hbs A, F, and S (pH range: 6.0–8.0). Lane 1: AS control; lane 2:
AF control; lanes 3–6: proband and proband’s mother, brother, and sister, respectively; lane 7: AA
control. c) Polyacrylamide gel electrophoresis in the presence of Urea Triton X-100 of the globin
chains. Top: anode; bottom: cathode. P: proband; M: proband’s mother; N: newborn normal control.
d) b-Globin gene sequencing showing the replacement AAG!CAG as the molecular basis of Hb
Pocos de Caldas.
a)
b)
c)
386 KIMURA ET AL.
©2002 Marcel Dekker, Inc. All rights reserved. This material may not be used or reproduced in any form without the express written permission of Marcel Dekker, Inc.
MARCEL DEKKER, INC. • 270 MADISON AVENUE • NEW YORK, NY 10016
Hem
oglo
bin
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f C
onne
ctic
ut o
n 10
/30/
14Fo
r pe
rson
al u
se o
nly.
and P5 (50-CCCTTCTTCCTATGACATGAACTTAACCAT-30) (spanning from
position �140, relative to the Cap site, to position þ521, at the beginning of
IVS-II).[4] The amplification reactions were carried out in a 50mL volume
containing 500 ng of genomic DNA, 50 ng of each primer (P1þP5), 50 mM of
each dNTP, 1X polymerase chain reaction (PCR) buffer (Taq polymerase buffer),
and 2.5 units of Taq DNA polymerase (Amersham Pharmacia Biotech,
Piscataway, NJ, USA). The PCR conditions were as follows: initial denaturation
for 2 mins at 94�C, followed by 35 cycles of 30 seconds at 94�C for denaturation,
45 seconds at 64�C for annealing, and 1 min at 72�C for extension, and a final
extension of 7 mins at 72�C, using a Perkin Elmer Cetus (Norwalk, CT, USA) PCR
thermocycler. Direct sequencing of the PCR products was performed by using the
Big DyeTM Terminator Cycle Sequencing Kit and the ABI PRISMTM 377
Genetic Analyzer (PE Applied BioSystems, Foster City, CA, USA), with primer
P2 (50-TTTGCTTCTGACACAACTGT-30).[4] A base substitution was detected at
codon 61 (AAG!CAG), causing the replacement Lys!Gln in the corresponding
position of the b chain (Fig. 1d). This mutation was confirmed by sequencing the
Figure 1. Continued.
Table 1. Hematological Data of the Hb Pocos de Caldas (PC) Carrier and Her Family
Parameters Proband Mother Brother Sister
RBC (1012=L) 4.65 4.26 5.41 3.98
Hb (g=dL) 14.4 13.3 15.5 11.9
PCV (L=L) 0.451 0.403 0.477 0.367
MCV (fL) 97.0 95.0 87.0 92.0
MCH (pg) 30.9 31.3 28.7 29.8
RDW (%) 15.0 15.5 18.4 15.5
Electrophoretic
profile
A2þAþ PC A2þAþ PC A2þAþ PC A2þAþ PC
Hb A2 (%) 2.37 2.60 2.25 2.34
Hb F (%) 0.66 0.90 0.76 0.45
d)
Hb POCOS DE CALDAS [b61(E5)Lys!Gln] 387
©2002 Marcel Dekker, Inc. All rights reserved. This material may not be used or reproduced in any form without the express written permission of Marcel Dekker, Inc.
MARCEL DEKKER, INC. • 270 MADISON AVENUE • NEW YORK, NY 10016
Hem
oglo
bin
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f C
onne
ctic
ut o
n 10
/30/
14Fo
r pe
rson
al u
se o
nly.
DNA opposite strand and familial analysis, which revealed that the carrier’s
mother, brother, and sister also have the same b-globin alteration (see Table 1).
This is the fourth description of a mutation at b61(E5)Lys: Hb N-Seattle
(!Glu) was found in a Black American blood donor,[5] Hb Hikari (!Asn)
detected in a Japanese family[6] and Hb Bologna (!Met) encountered in a North
Italian family.[7] The mutations found at this position (external contacts of the Hb
molecule) do not cause clinical manifestations, since all the carriers described so
far have been asymptomatic.
ACKNOWLEDGMENTS
Funding came from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
(FAPESP) (grant 1997=11725-1) and Conselho Nacional de Desenvolvimento Cientıfico
e Tecnologico (CNPq), Brazil.
REFERENCES
1. Dacie, J.V.; Lewis, S.M. Practical Haematology, 8th Ed; Churchill Livingstone:
London, England, 1995.
2. Alter, B.P.; Goff, S.C.; Efremov, G.D.; Gravely, M.E.; Huisman, T.H.J. Globin Chain
Electrophoresis: A New Approach to the Determination of the Gg=Ag Ratio in Fetal
haemoglobin and to Studies of the Globin Synthesis. Br. J. Haematol. 1980, 44,
527–534.
3. Rossi-Fanelli, A.; Antonini, E. Studies on the Oxygen and Carbon-Monoxide
Equilibria of Human Myoglobin. Arch. Biochem. Physiol. 1958, 77, 428–492.
4. Miranda, S.R.P.; Fonseca, S.F.; Figueiredo, M.S.; Yamamoto, M.; Grotto, H.Z.W.;
Saad, S.T.O.; Costa, F.F. Hb Koln [a2b2 98 (FG5) Val!Met] Identified by DNA
Analysis in a Brazilian Family. Braz. J. Genet. 1997, 20, 745–748.
5. Jones, R.T.; Brimhall, B.; Huehns, E.R.; Motulsky, A.G. Structural Characterization
of Hemoglobin N Seattle: a2Ab2 61 Lys!Glu. Biochim. Biophys. Acta 1968, 154,
278–283.
6. Nakatsuji, T.; Miwa, S.; Hattori, Y.; Ohba, Y.; Miyaji, T.; Miyata, H.; Shinohara, T.;
Matsui, Y. A Further Example of Hemoglobin Hikari (b61[E5]Lys!Asn).
Hemoglobin 1981, 5 (5), 487–492.
7. Marinucci, M.; Giuliani, A.; Maffi, D.; Massa, A.; Giampaolo, A.; Mavilio, F.;
Zannotti, M.; Tentori, L. Hemoglobin Bologna (a2b2 61 (E5) Lys!Met) an
Abnormal Human Hemoglobin With Low Oxygen Affinity. Biochim. Biophys. Acta
1981, 668, 209–215.
Received May 24, 2002
Accepted July 4, 2002
388 KIMURA ET AL.
©2002 Marcel Dekker, Inc. All rights reserved. This material may not be used or reproduced in any form without the express written permission of Marcel Dekker, Inc.
MARCEL DEKKER, INC. • 270 MADISON AVENUE • NEW YORK, NY 10016
Hem
oglo
bin
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f C
onne
ctic
ut o
n 10
/30/
14Fo
r pe
rson
al u
se o
nly.